Press Releases and Statements

Browse Press Releases and Statements Content

Dec 2, 2022

The Consumer Healthcare Products Association (CHPA) today released findings from its 2022 Over-The-Counter (OTC) Value Study, once again showing that self-care with OTC medicines not only benefits individuals but also benefits the entire healthcare system.

Dec 1, 2022

CHPA Submits Comments on FDA Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use

Nov 22, 2022

(NEW YORK) – The Consumer Healthcare Products Association (CHPA) Educational Foundation held its 7th Annual Gala last night at the Plaza Hotel in New York City.

Nov 17, 2022

The Consumer Healthcare Products Association (CHPA) Educational Foundation today announced an educational pilot launch to help consumers choose over-the-counter (OTC) pain relievers at the point of purchase

Nov 14, 2022

“As flu season begins, CHPA remains in close contact with our member companies who are currently meeting the elevated demand for safe and effective children’s pain reliever products.

Nov 11, 2022

Consumer Healthcare Products Association (CHPA) responds to findings from the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study published in the Journal of the American College of Cardiology.

Nov 6, 2022

Jay Sirois, PhD, CHPA’s vice president of regulatory & scientific affairs, and co-author of the paper, Considerations for determining safety of probiotics: A USP perspective

Oct 27, 2022

The Consumer Healthcare Products Association (CHPA) applauds the U.S. Food and Drug Administration’s (FDA) final rule establishing a regulatory category for over-the-counter (OTC) hearing aids which will officially take effect Monday.

Oct 13, 2022

(WASHINGTON, DC) – Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, today released the below statement following congressional passage of a short-term spending package to fund the Federal Government through Dec. 16. Included in this Continuing Resolution is legislation to reauthorize the U.S. Food and Drug Administration’s (FDA) user fee programs for prescription drugs, generic drugs, biosimilars, and medical devices over the next five years.

Sep 30, 2022

(Bethesda, MD) – The Consumer Healthcare Products Association (CHPA) today announced its first-ever Regulatory & Scientific Affairs Career Achievement Award winners at its annual Regulatory, Scientific & Quality (RSQ) conference in Bethesda.

Sep 20, 2022

Filter Results